Literature DB >> 6581172

Utilization of monoclonal antibodies and immuno-scanning electron microscopy for the positive identification of human leukemic cells.

H Gamliel, D Gurfel, A Polliack.   

Abstract

Monoclonal antibodies generated against normal and leukemic human leukocytes were tested for their differential reactivity with leukemia and lymphoma cell lines as well as with circulating lymphoid and myeloid leukemic cells by means of immuno-scanning electron microscopy (immuno-SEM). Anti-T (OKT3), anti-mu-chain, anti-CALLA (J5), anti-BA-1, anti-BA-2, and anti-nonlymphoid (Mol) monoclonal antibodies were covalently conjugated to polystyrene latex microspheres (immunolatex), using a two-step glutaraldehyde reaction, and subsequently incubated with the various cell types. Cultured B-type Burkitt lymphoma cells (Daudi) and chronic lymphocytic leukemia (CLL) cells displayed extensive labeling with monoclonal anti-mu, anti-B1, and anti-BA-1 immunolatex conjugates, while cultured malignant T cells (HD-Mar) showed positive labeling with OKT3 immunolatex alone. Cultured myelomonocytic cells (GDM-1) and cells obtained from patients with acute myeloblastic (AML) and monoblastic leukemia (AMoL) labeled only with anti-Mol immunolatex, while cultured promyelocytic cells (HL-60) displayed far less labeling with this conjugate. Common-type acute lymphoblastic leukemia (C/ALL) cells were labeled predominantly with the J5 (anti-CALLA) and anti-BA-2 immunolatex conjugates. Evidence is presented indicating that immuno-SEM employing monoclonal antibodies is a reproducible technique which may be used in the study of leukocyte maturation and may provide additional information in the classification of poorly differentiated leukemias.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6581172     DOI: 10.1007/bf00915802

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  30 in total

1.  Scanning immunoelectron microscopy markers.

Authors:  H Gamliel; A Polliack
Journal:  Isr J Med Sci       Date:  1979-08

2.  Characterization of a human B lymphocyte-specific antigen.

Authors:  P Stashenko; L M Nadler; R Hardy; S F Schlossman
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

3.  Multimarker classification of acute lymphoblastic leukemia: evidence for further T subgroups and evaluation of their clinical significance.

Authors:  E Thiel; H Rodt; D Huhn; B Netzel; H Grosse-Wilde; K Ganeshaguru; S Thierfelder
Journal:  Blood       Date:  1980-11       Impact factor: 22.113

4.  Detection of T and B cell antigens hybridoma monoclonal antibodies: a biotin-avidin-horseradish peroxidase method.

Authors:  R Warnke; R Levy
Journal:  J Histochem Cytochem       Date:  1980-08       Impact factor: 2.479

5.  Immunolatex visualisation of cell surface Forssman and polyamine antigens.

Authors:  G A Quash; A Niveleau; M Aupoix; T Greenland
Journal:  Exp Cell Res       Date:  1976-03-15       Impact factor: 3.905

6.  Positive identification of human leukaemic cells with scanning immuno-electron microscopy, using antibody coated polystyrene (latex) beads as markers.

Authors:  H Gamliel; A Polliack
Journal:  Scand J Haematol       Date:  1981-04

7.  A monoclonal antibody identifying a cell surface antigen shared by common acute lymphoblastic leukemias and B lineage cells.

Authors:  M F Greaves; W Verbi; J Kemshead; R Kennett
Journal:  Blood       Date:  1980-12       Impact factor: 22.113

8.  Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1976-08       Impact factor: 6.998

9.  Antigens on human monocytes identified by monoclonal antibodies.

Authors:  R F Todd; L M Nadler; S F Schlossman
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

Review 10.  Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma.

Authors:  J Ritz; S F Schlossman
Journal:  Blood       Date:  1982-01       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.